We hypothesize that increased mu-opioid receptor expression on B cells, triggered by the HPV vaccine acting as a mu-agonist, might lead to negatively regulated pain perception and other physiological processes and, consequently, the decreased risk of fibromyalgia. Here, OPRM1 is linked to fibromyalgia.